HARROW, INC. — Director's Dealing 2023

Jul 21, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2023-07-18

Reporting Person: SAHAREK JOHN P. (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-18	Common Stock	M	277200	—	Acquired	331277	Direct
2023-07-18	Common Stock	F	109080	$18.23	Disposed	222197	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-18	Performance Stock Unit	$	M	277200	Disposed		Common Stock (277200)	Direct

Footnotes

F1: The 277,200 shares of Harrow Health, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares issued based on vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on July 23, 2021. The PSUs were settled in full (on a one-for-one basis) on July 18, 2023, following attainment of total stockholder return targets ranging from 50% - 175 % following the date of the award. The 109,080 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.